Breaking Barriers: The Role of the Bone Marrow Microenvironment in Multiple Myeloma Progression

Aleksandra Agafonova1, Chiara Prinzi1, Angela Trovato Salinaro2

  • 1Department of Biomedical and Biotechnological Sciences, Section of Medical Biochemistry, University of Catania, 95123 Catania, Italy.

Insights

Multiple myeloma (MM) is a bone marrow cancer. The bone marrow barrier (BMB) supports cancer cell survival, suggesting that targeting MM cell and BMB interactions could be a new therapy.

Area of Science:

  • Oncology
  • Hematology
  • Cell Biology

Background:

  • Multiple myeloma (MM) is an incurable cancer of abnormal plasma cells.
  • These cells proliferate in the bone marrow and can spread to other sites.
  • The bone marrow barrier (BMB) is crucial for MM cell homing and disease advancement.

Purpose of the Study:

  • To review the components of the bone marrow barrier (BMB).
  • To examine the pathways involved in multiple myeloma (MM) pathogenesis.
  • To explore targeting MM cell and BMB interactions for novel therapies.

Main Methods:

  • Literature review of MM pathogenesis.
  • Analysis of BMB components and their role in MM.
  • Examination of molecular interactions between MM cells and BMB cells.

Main Results:

  • The BMB comprises bone marrow endothelial cells (BMECs) and bone marrow stromal cells (BMSCs).
  • BMECs and BMSCs interact with MM cells, secreting factors that promote MM cell survival and proliferation.
  • Key pathways involve adhesion molecules, angiogenic cytokines, anti-apoptotic factors, and growth signals.

Conclusions:

  • The BMB microenvironment significantly supports MM progression.
  • Understanding MM cell-BMB interactions is key to MM pathogenesis.
  • Targeting these interactions presents a promising therapeutic strategy for MM.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
495
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K